These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1728411)

  • 1. Human xenograft-nude mouse model of adoptive immunotherapy with human melanoma-specific cytotoxic T-cells.
    Crowley NJ; Vervaert CE; Seigler HF
    Cancer Res; 1992 Jan; 52(2):394-9. PubMed ID: 1728411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytotoxic T-cells suppress the growth of spontaneous melanoma metastases in SCID/hu mice.
    Sabzevari H; Reisfeld RA
    Cancer Res; 1993 Oct; 53(20):4933-7. PubMed ID: 8402683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced anti-metastatic efficacy of IL-2 activated NK (A-NK) cells with novel benzothiazoles.
    Goldfarb RH; Kitson RP; Brunson KW; Yoshino K; Hirota N; Kirii Y; Kotera Y; Inoue Y; Ohashi M
    Anticancer Res; 1999; 19(3A):1663-7. PubMed ID: 10470098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
    Kawaoka T; Oka M; Takashima M; Ueno T; Yamamoto K; Yahara N; Yoshino S; Hazama S
    Oncol Rep; 2008 Jul; 20(1):155-63. PubMed ID: 18575732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ineffectiveness of adoptive chemoimmunotherapy with lymphokine-activated killer cells, interleukin-2, and cyclophosphamide on palpable intradermal murine bladder cancer.
    Lee K; O'Donnell RW; Cockett AT
    J Biol Response Mod; 1988 Feb; 7(1):43-53. PubMed ID: 3259620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
    Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F
    Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas.
    Crowley NJ; Slingluff CL; Darrow TL; Seigler HF
    Cancer Res; 1990 Feb; 50(3):492-8. PubMed ID: 2404572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the Interleukin-6 gene using adenovirus vector.
    Tanaka F; Abe M; Akiyoshi T; Nomura T; Sugimachi K; Kishimoto T; Suzuki T; Okada M
    Cancer Res; 1997 Apr; 57(7):1335-43. PubMed ID: 9102222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor activity of class II MHC antigen-restricted cloned autoreactive T cells. II. Novel immunotherapy of B16 melanomas by local and systemic adoptive transfer.
    Shiohara T; Moellmann G; Jacobson K; Kuklinska E; Ruddle NH; Lerner AB
    J Immunol; 1987 Mar; 138(6):1979-86. PubMed ID: 3493292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antitumor effect of cytotoxic T lymphocytes engineered to produce interferon-gamma by adenovirus-mediated genetic transduction.
    Abe J; Wakimoto H; Tsunoda R; Okabe S; Yoshida Y; Aoyagi M; Hirakawa K; Hamada H
    Biochem Biophys Res Commun; 1996 Jan; 218(1):164-70. PubMed ID: 8573124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
    Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H
    Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy.
    Rolle CE; Carrio R; Malek TR
    Cancer Res; 2008 Apr; 68(8):2984-92. PubMed ID: 18413768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of immunogenic pulmonary metastases in the presence of protective anti-melanoma immunity.
    Donawho CK; Pride MW; Kripke ML
    Cancer Res; 2001 Jan; 61(1):215-21. PubMed ID: 11196164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2.
    Roychowdhury S; May KF; Tzou KS; Lin T; Bhatt D; Freud AG; Guimond M; Ferketich AK; Liu Y; Caligiuri MA
    Cancer Res; 2004 Nov; 64(21):8062-7. PubMed ID: 15520217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ; Yang J; Shu S; Rosenberg SA
    J Immunol; 1986 May; 136(10):3899-909. PubMed ID: 2871106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs.
    Machlenkin A; Uzana R; Frankenburg S; Eisenberg G; Eisenbach L; Pitcovski J; Gorodetsky R; Nissan A; Peretz T; Lotem M
    Cancer Res; 2008 Mar; 68(6):2006-13. PubMed ID: 18339883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel system for simultaneous in vivo tracking and biological assessment of leukemia cells and ex vivo generated leukemia-reactive cytotoxic T cells.
    Sauer MG; Ericson ME; Weigel BJ; Herron MJ; Panoskaltsis-Mortari A; Kren BT; Levine BL; Serody JS; June CH; Taylor PA; Blazar BR
    Cancer Res; 2004 Jun; 64(11):3914-21. PubMed ID: 15173002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: critical roles of IFN-inducible protein-10.
    Nishimura F; Dusak JE; Eguchi J; Zhu X; Gambotto A; Storkus WJ; Okada H
    Cancer Res; 2006 Apr; 66(8):4478-87. PubMed ID: 16618775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of tumor antigen specific CTL induced by dendritic cells on a model of human hepatocellular carcinoma in nude mice (LCI-D20)].
    Chen GL; Hu HD; Ma YJ; Li YG; Xue Q; Chen M; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):431-4. PubMed ID: 16792867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.